SUMMARY Splenic blood flow has been measured in the dog using indium labelled autologous platelets (SBF,) and compared with splenic blood flow measured with an electromagnetic flowmeter placed on the splenic vein (SVBF). The overall correlation between SBF, and SVBF was only moderately close (r=0.54, P<O.Ol) and SBFp was about half SVBF. When expressed as a change between sequential measurements in an individual animal, the correlation between SBF, and SVBF was closer (r=0.85, P<O.OOl). It was concluded that SBF, is a specific measure of splenic pulp blood flow and that the discrepancy between SBF, and SVBF reflects the degree of splenic blood flow bypassing the pulp.
A noninvasive method for measuring s lenic blood flow (SBF) was recently described by us. p-3 It is based on the physiological phenomenon of intrasplenic platelet pooling, and, using platelets radiolabelled with indium-1 1 1, measures the turnover of platelets between circulating blood and the intrasplenic pool.
Although the model of splenic platelet pooling, extensively studied by Aster and co-workers4 is widely accepted and was validated in man and the dog by Peters et al' using indium labelled platelets, the method of SBF measurement based on it has not been directly validated. Quantitative estimates of SBF may be useful, as for example in relation to the assessment of splenic function using radiolabelled modified red cell clearance6 which is clearly dependent, among other factors, on SBF. We have therefore compared SBF, estimated using indium labelled platelets (SBF,) with SBF measured directly with the electromagnetic flowmeter (SVBF) in the anaesthetised dog. In addition, we have taken the opportunity to compare SBF with other parameters of splenic haemodynamics.
Measurement of splenic bloodflow in the anaesrhetised dog
Medical Instruments). The gastroduodenal and right gastric arteries were ligated to ensure that true hepatic arterial flow was measured by the probe. The gastroduodenal vein was ligated and a catheter inserted into the portal vein for portal pressure measurement.
PLATELET LABELLING
In order to maximise the number of SBF, measurements in each dog, both indium-11 1 and the short-lived isotope, indium-1 I3m, were utilised for platelet labelling. Using the labelling technique to be described, these two indium isotopes are interchangeable. 20 ml of femoral arterial blood was obtained in 3 ml of acid citrate dextrose (ACD -NIH formula A). This was diluted with 10 ml 1.5 molelitre-' NaCl and then centrifuged at 150 g for 10 min. The platelet rich, dilute plasma was removed, and, following the addition of further ACD (1 part to 20 parts dilute plasma) was centrifuged at 650 g for 10 min to yield a platelet pellet. After removal of the platelet poor plasma the platelet pellet was resuspended in 5 ml of 1.5 mol-litre-' NaCl containing Hepes buffer (20 mmol-litre-') and acetylacetone (Sigma) at a concentration of 0.19%.* Indium-1 1 1 (Amersham International) or indium-1 13 m from a sterile generator (Amersham International) was then added to the platelet suspension. Both these isotopes are dispensed in 0.04 mol-litre-' HCl and were added to the platelet suspension (pH 7.6) in volumes of no greater than 0.2m1, which ensures that the pH does not fall below 6.5. Isotope activity was chosen according to the sequence of injections (see below). After 5 rnin incubation at room temperature without agitation, 5 ml of dilute cell-free plasma was added and the platelets resedimented at 650 g for 5 min. After removal of supernatant, containing non-cell-bound indium, the platelets were resuspended in further cell free dilute plasma. Based on the extent of red cell contamination and the relative selectivity of indium-acetylacetonate for platelets, at least 95% of the activity was estimated to be present in platelets.
4 SBF, In six dogs, three measurements of SBF, were performed, and in a further animal, four. The first injected platelet aliquot was labelled with indium-1 11 and the dose about 50 pCi. This was followed by about 200 pCi of indium-113m labelled platelets. The third injection was indium-1 1 1 labelled platelets in a dose of 200 to 300 pCi. In one dog, a fourth injection of 300 pCi indium-1 13m labelled platelets was administered.
Scintillation probes (with approximately 2.5cm lead collimation), were positioned over the left lateral aspect of the lower abdominal wall and either the right anterio-lateral chest (five dogs) or the right lateral 711 aspect of the neck (two dogs), to continuously record activity in the spleen and circulating blood. They were connected to a dual channel counter-ratemeter (J & P Engineering). Following adequate recording of the background count rate, the aliquot of labelled platelets was given by bolus injection into a peripheral vein and activity recorded directly from the ratemeters at intervals initially of 30 s and later, of 1 min. Because indium-I 13m has a higher photopeak (392 KeV) than indium-111 (170 and 247 KeV) the first two measurements of SBF, were uncomplicated by significant background count rates, which were almost zero. For the third measurement, background consisted of both indium-1 1 1 and indium-1 13m components, the relative contributions of which were calculated on the basis of the equilibrium count rate achieved at the end of the Frst SBF, measurement. A knowledge of these components is necessary since indium-1 13m decay throughout a measurement is significant (half time 100 min) and has to be calculated. In any event, the relative magnitude of the background count rate was small in the third run because of the increased indium-11 1 dose. When a second indium-113m injection was given, background consisted only of indium-113m. At about 3 min following injection and at the termination of a measurement femoral arterial blood samples of 5 ml were taken for estimation of cell bound and plasma activities (see below).
In five dogs, SBF, was measured during constriction of the splenic artery by constant traction on a previously positioned snare. Before commencing the SBF, determination, it was established that SVBF was constant.
DATA ANALYSIS (FIG 1)
Time activity curves over the spleen and blood pool were corrected for background activity. Each value on indium-1 13 m curves was corrected for isotope decay (half-life 100 min). Activity in the blood pool and spleen approached equilibrium values monoexponentially. The rate constant of uptake over the spleen (Ks) was calculated using a computerised maximum likelihood estimate. The blood pool time activity curve was fitted as follows. The 3 min value was taken as zero, and subsequent points subtracted from the 3 min value. A computerised maximum likelihood estimate was then fitted to these differences, from which the rate constant of equilibration (Kb) and the equilibrium blood pool count rate (Qeq) were obtained. Using Kb and Qeq, the extrapolated activity at 1 min (chosen to allow for intravascular mixing) was calculated. The ratio of Qeq to the 1 min activity was taken as the platelet recovery (R), and the fraction of the circulating activity present in the spleen at equilibrium (Qs) as 1-R. SBF, was
-

INTRASPLENIC ARTERIAL INJECTIONS
In two animals (dogs six and seven) aliquots of indium-1 1 1 -labelled platelets were given by direct splenic arterial injection following insertion of a 2 1 g butterfly needle (Abbott) at the end of the study. Samples of femoral arterial blood were taken prior to this injection and at frequent intervals up to 40 min. Activities in lml whole blood and 1 ml cell free plasma were counted in a Packard gamma counter (model 5360) and cell bound activity calculated from the haematocrit . Peripheral blood time activity curves were then constructed by subtraction of the preinjection value. between measurements. The product of R and Ks is equal to the splenic platelet clearance (K2), the reciprocal of which is the mean intrasplenic platelet transit time. An alternative to the compartmental analysis just described for the measurement of K2 is deconvolution analysis' which makes use of the splenic and blood pool time activity curves to predict the time activity curve that would be obtained if the platelets were injected as a bolus directly into the splenic artery and did not recirculate; ie it predicts the splenic "washout" of platelets. The rate constant of this washout profile is then equal to K2.
STATISTICS
Linear parametric regression analysis was utilised for comparisons of variables.
1 LABELLED PLATELET DATA Plasma indium activity was consistently less than 10% of the whole blood activity, and in most cases less than 5%. Labelled platelet data is summarised in 
HAEMODYNAMIC CORRELATIONS (EXCLUDING CONSTRICTION)
MEASUREMENTS DURING SPLENIC ARTERIAL a) Blood flow SVBF showed weak but significant (PC0.05) correlations with hepatic arterial blood flow and total liver blood flow but no significant correlation with portal blood flow or, when expressed as a percentage of total blood volume, the hepatic arterial fraction of liver blood flow. SBF, was not correlated with any of the above parameters except the hepatic arterial fraction (r = 0.64, P = 0.01). The hepatic arterial fraction also correlated with the ratio SBF, : SVBF (r = 0.67, PtO.O1).
b) Blood pressure (fig 8)
Mean arterial blood pressure correlated significantly with SVBF (r = 0.58, Pt0.05) and with SBF, (r = 0.7, Pt0.002) when they were expressed as a fraction of total blood volume, but not with the ratio SBF, : SVBF (r = 0.44, P>0.05) or with the hepatic arterial fraction of liver blood flow (r = 0.41, P>O.OS). As blood pressure decreased there was a trend for SBF, to decrease more than SVBF (respective slopes of 0.72 difference was not significant. The y-axis intercept of SBF,, however, was significantly lower than that of SVBF (fig 8) increased slightly (by about 25% of the 2 min value) between 2 to 40 min after injection. One of these dogs was inadvertently allowed to become hypoxic. Activity in the blood increased during this hypoxic episode whereas that in the spleen decreased.
We have found that SBF measured using indium labelled platelets underestimates SBF simultaneously measured with the electromagnetic flowmeter, SBF, being approximately half SVBF. Because the flowmeter was placed over the splenic vein rather than the artery (in order to leave the artery free for constriction and injections), and was therefore not recording splenic outflow passing into the short gastric veins, the true discrepancy between SBF, and SVBF may be even greater. On the other hand, since the model upon which SBF, measurement is based defines K1 as the fraction of extra-splenic blood volume entering the spleen in unit time, SBF, may also have been underestimated. There was great variability from dog to dog not only in the values of SVBF and SBF, but also in their ratio, explaining why the correlation between SVBF and SBF, was relatively poor. However, when simultaneous changes in SVBF and SBF, (both spontaneous and induced) are considered, the correlation becomes much more significant and the regression equation approaches unity. This is good evidence that indium labelled platelets are indeed measuring some parameter related to splenic blood flow. Further evidence validating the model of splenic platelet pooling is that the intrasplenic transit time distribution of labelled platelets obtained from' deconvolution analysis closely approximated a monoexponential, consistent with a single well-mixed intrasplenic pool (fig 4) . Furthermore, the rate constants of this exponential agreed with those simultaneously obtained from compartmental analysis.
Assuming that the flowmeter gives an accurate value for SBF, there are four possible explanations for the appreciably lower values of SBF, as compared with SVBF. 1 Some irreversible extraction of labelled platelets in the lungs on first pass, may have given a spuriously high value of R. Evidence for this is that R values were lowest in one of the two dogs in whom blood pool activity was recorded by a probe over the neck. However stronger evidence against it is the finding that peripheral whole blood pool activity displayed a decrement almost identical to that of the activity recorded by probe. 2 R values may have been spuriously elevated by free plasma indium, which has a relatively slow rate of clearance. However, plasma indium was consistently very low and would have had very little effect on R. Free indium, incidentally is not appreciably taken up by the spleen. lo 3 Other sites of platelet pooling may exist within the body, tending to give a higher apparent volume of distribution than blood volume. Strong candidates for such sites would be liver" and lung." l 3 Although they would have to have a total apparent volume equivalent to the extrasplenic blood volume in order to account for the observed discrepancies between SBF, and SVBF, extra-splenic platelet pools are difficult to exclude. Their identification would necessitate quantitative scanning and/or radio-labelled red cell studies. Neither of these techniques was considered feasible in our study. Evidence against significant extra-splenic platelet pooling is the finding of a brood pool time activity curve which was monoexponential from 2 to 3 min onwards with respect to its equilibrium value and with a rate constant which closely correlated with the rate constant of simultaneous equilibration recorded over the spleen. Multiple sites of platelet pooling would be expected to produce a blood time activity curve which, with respect to the equilibrium value, was multi-exponential. Clearly, with respect to this problem, further probes would have been an advantage. In any event, although we cannot definitely exclude extra-splenic sites of platelet pooling in the anaesthetised dog, they are, with the possible exception of the liver, not present in the intact conscious human to any significant extent as has been demonstrated by quantitative ~c a n n i n g '~-'~ and dynamic imaging.' l4 With regard to the liver, it is not certain whether indium labelled platelet uptake represents pooling or irreversible removal of damaged cells. Liver uptake in the human, which produces an early rapid exponential in the blood pool time activity curve, can be accounted for in the calculation of SBF,.' '' Significant irreversible liver uptake in the dog was minimal as evidenced by the reciprocal symmetry of the blood pool and splenic time activity
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curves from as early as 2 min after injection and the absence of an early rapid exponential in the blood pool time activity curves. In the study of Lotter et al, who used a similar labelling technique to our own, early liver uptake, although representing 20% of the dose, reached its maximum within 2 min of platelet re-injection. This would have suggested pooling within the liver except that the activity subsequently remained constant and did not fall in parallel with the blood pool activity. The remainder of the dose was accounted for in the spleen and circulating blood, arguing against pooling elsewhere. 4 Intra-splenic "shunting" could account for the observed discrepancy between SBF, and SVBF. The labelled platelet technique theoretically measures inflow into the sites of platelet pooling within the spleen, presumably the splenic pulp. If half the inflowing blood by-passed the pulp, then SVBF would be expected to be twice SBF,. Evidence for this explanation comes from three sources. Firstly, the value of Ks recorded by Lotter et al,19 following injection of indium-1 11 labelled platelets in the intact, conscious dog was 0.26 min-' , very much higher than our mean value of 0.084 min-' (k SE 0.012) (excluding measurements during which the splenic artery was constricted), and a value in keeping with the relatively large dog spleen. In contrast, the mean value of Ks in humans recorded by this group was 0.135 which is very similar to our own values.' '' Clearly, surgery and/or anaesthetisation in the dog causes very considerable perturbation of splenic haemodynamics. Secondly, as reported in the present paper, direct intra-splenic arterial injection of indium labelled platelets resulted in a "flat" peripheral blood time activity curve, increasing slightly (by about 25%) between 2 min and 40 min. Theoretically, if, at equilibrium, there are twice as many platelets in the circulating blood as in the spleen, this time activity curve would be similar to that produced by simultaneous injection of equal doses of platelets into the two compartments of the closed system, consistent with about half the platelets by-passing the pulp following intra-splenic arterial injection. In contrast, the peripheral venous time activity curve recorded following intra-splenic arterial injection of indium-1 1 1 labelled platelets in humans resembled the splenic uptake curve recorded following peripheral venous injection,' suggesting that essentially all the splenic in flow serves the pulp in the human. SBF, in the anaesthetised dog, might, therefore be regarded as a measure of splenic pulp flow rather than total splenic blood flow, and the ratio SBF, : SVBF as a measure of intrasplenic blood flow "shunting". Since SBF measured by intra-arterial Xenon-133 has been found to agree with SBF by flowmeter:' '' such "shunting" presumably represents splenic sinus flow. Thirdly, the min-' 14 splenic venous time activity curve recorded in the dog following peripheral venous labelled platelet injection commenced (allowing 2 min for arrival at the splenic vein) with a count rate of about half the equilibrium count rate. ' Although it was not the primary purpose of this study to investigate the relationship of splenic haemodynamics to other splanchnic haemodynamic parameters, it is of interest to note that mean arterial blood pressure correlated significantly with SBF, and SVBF, but not with the ratio SBF, : SVBF. The significant difference between the y-axis intercepts of the regressions of SVBF and SBF, on mean arterial blood pressure predicts that SBF, would become zero at a blood pressure (about 90 mmHg) at which SVBF was still 2.5% of total blood volume per min. The respective regression slopes of SVBF and SBF, versus arterial blood pressure (fig 8) bore a relationship to each other that is strikingly similar to that observed by Vaupel et a12= between the respective regression slopes of total SBF and splenic pulp flow versus mean arterial blood pressure in the rat. Other interesting, moderately significant, correlations were noted between the ratio of hepatic arterial to total liver blood flow (HABFLBF) and a) SBF, and b) SBF,:SVBF. HABF:LBF did not however correlate significantly with mean arterial blood pressure, suggesting that hypotension was not a common factor responsible for the observed correlation between HABF:LBF and SBF,:SVBF. Although the significance of these correlations is uncertain, and they should be interpreted cautiously, it is interesting to speculate that there may be common mechanisms controlling these two ratios.
In conclusion, we have shown that the intra-splenic kinetics of the anaesthetised dog are different from those of the intact human subject. These differences suggest that the dog is not an ideal experimental animal in which to validate SBF measurement based on platelets in humans. Nonetheless, changes in SBF, and SVBF parallelled each other sufficiently closely to suggest that the technique does indeed measure the splenic pool inflow. The observed haemodynamic relationships suggest that further studies on the effect of controlled hypotension on the intra-splenic distribution of blood flow would be of interest.
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